Search for: "G&A" Results 5081 - 5100 of 15,180
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jun 2008, 8:15 pm
Like Ply Mart, Wheeler's saw its sales drop from a peak of $20 million a month to $4 million a month and saw its accounts receivable "getting staler and staler," said G. [read post]
4 Jan 2023, 5:06 pm by Edwin Astudillo and Seth Lemings
The following examples would violate Rule 100(b) of Regulation G: Failure to identify and describe a measure as non-GAAP. [read post]
17 Jul 2008, 8:10 am
  Last night was the 40th birthday party for my former protégé's wife, on a roof garden atop a Fifth Avenue penthouse in midtown. [read post]
22 Jun 2009, 9:23 am
  And it is also speculation, but it may well be that Chief Justice John G. [read post]
28 Aug 2007, 2:11 pm
  As but one example, I'll hold out the recent work of Thomas G. [read post]
20 Sep 2008, 2:09 pm
Chapter 11 reorganization is “a fairly expensive process if you can’t preserve equity or if the banks won’t give you time,” said G. [read post]
17 Apr 2009, 7:18 am
  Countenance in the context of authorizing copyright infringement must be understood in its strongest dictionary meaning, namely, “[g]ive approval to; sanction, permit; favour, encourage. [read post]
21 Feb 2019, 8:05 am by Sara Amundson
Overall, P&G has invested more than $420 million over 40  years in developing non-animal test methods and its researchers have led or co-designed at least 25 cruelty-free methods for testing cosmetic products. [read post]
19 Feb 2019, 4:18 am by Andrew Lavoott Bluestone
Kroll & Assoc., PLLC, 106 AD3d 1037, 1038; see Quinn v McCabe, Collins, McGeough & Fowler, LLP, 138 AD3d at 1086). [read post]
30 Dec 2019, 9:34 am by Nancy E. Halpern, D.V.M.
  FDA considers these products to be unapproved new drugs or unapproved new animal drugs pursuant to section 201(g)(1) of the Federal Food Drug and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1), stating, that the products intended for use by people: are not generally recognized as safe and effective for the above referenced uses and, therefore, the products are ‘new drugs’ under section 201(p) of the FD&C Act, 21 U.S.C. 321(p). [read post]
13 Feb 2012, 5:00 am by Jon Robinson
Claims Arising on the Outer Continental Shelf: Kenneth G. [read post]
10 Feb 2020, 4:36 am by Andrew Lavoott Bluestone
Kroll & Assoc., PLLC, 106 AD3d 1037, 1038 [2013]; see Quinn v McCabe, Collins, McGeough & Fowler, LLP, 138 AD3d at 1086). [read post]